Related Experiment Video
Updated: Jul 17, 2026

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
Published on: February 24, 2026
Intrathecal tetanus immunoglobulins in the management of tetanus
M G Geeta1, P Krishnakumar, Lulu Mathews
1Department of Pediatrics, Medical College, Calicut, Kerala, India. geetakkumar@gmail.com
Insights
Intrathecal tetanus immunoglobulin (TIG) shows promise for treating pediatric tetanus, with lower mortality compared to intramuscular TIG. Further trials are needed for severe cases.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Immunology
Background:
- Tetanus remains a significant public health concern, particularly in unvaccinated populations.
- Intrathecal administration of tetanus immunoglobulin (TIG) is an alternative treatment strategy.
Purpose of the Study:
- To evaluate the clinical profile, treatment, and outcomes of pediatric tetanus cases managed with intrathecal TIG.
- To compare the efficacy of intrathecal TIG with other treatment modalities.
Main Methods:
- Retrospective analysis of hospital records for pediatric intensive care unit (PICU) admissions.
- Inclusion of 66 pediatric tetanus cases treated with intrathecal TIG between 1999 and 2004.
Main Results:
- The majority of cases (82%) involved unimmunized children, with otogenic (58%) and injury (30%) as common portals of entry.
- Observed complications included thrombophlebitis, aspiration pneumonia, laryngospasm, and autonomic system involvement.
- A 9% mortality rate was recorded, with no TIG-specific complications.
Conclusions:
- Intrathecal TIG demonstrated reduced mortality and morbidity compared to intramuscular TIG.
- Intrathecal TIG is effective for mild to moderate tetanus in children.
- Further randomized controlled trials are recommended for severe tetanus management.
Objective:
To study the clinical profile, treatment and outcome of tetanus in children treated with intrathecal tetanus immunoglobulin. (TIG) METHODS: Retrospective analysis of hospital records of tetaus cases admitted to the pediatric ICU during the five year period between 1999 to 2004 was done.
Results:
There were 66 cases of tetanus treated with intrathecal TIG. Children below 5 years formed 53% of cases and 47% were above 5 years. Totally unimmunized children constituted 82% of cases and 18% partially immunized children. The portal of entry was otogenic in 58% of cases and injury in30% of cases. The common complications observed included thrombophlebitis, aspiration pneumonia, laryngospasm and autonomic system involvement. There were no complications specific to intrathecal administration of TIG. The mortality due to tetanus was 9%.
Discussion:
Mortality and morbidity due to tetanus was less in the present study compared to other centers where TIG is given intramuscularly.
Conclusion:
Intrathecal TIG is effective in the treatment of mild and moderate tetanus. Randomized controlled clinical trials are needed to evaluate the efficacy of intrathecal TIG in the management of severe tetanus.
Related Concept Videos
Tetanus
Diphtheria
Botulism
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Skeletal Muscle Relaxants: Therapeutic Uses

